Merck & Co., Inc. (MRK) vs Microsoft Corporation (MSFT)

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.

Microsoft Corp develops and licenses software for both consumer and enterprise markets. The company is best known for its Windows operating systems and Office productivity applications. Its business is organized into three broadly equal segments: Productivity and Business Processes, which includes legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, and Dynamics; Intelligent Cloud, which includes Azure infrastructure- and platform-as-a-service offerings, Windows Server, and SQL Server; and More Personal Computing, which includes Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktop devices.